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be limited to altering numbers. depending only on whether 
cmm br r eporared from rbr genwol wdrrarional issrrrs 
srrrroanding provision of medical cm’. To conceive of 
manpower as a technical matter merely sidesteps the basic 
diffcrenccs in va!ues underlying policy choices. The result- 
ing confusion bewecn means and ends Iewes decisions 
vulnerable to the influence of values that remain both 
unexpressed and unexamined. If a smte follows federal 
practices in manpower policy, these unexpressed values are 
likely to be federal values rather than the state’s. 
IV. Conclusions and Recommendations 
l Tentative data on the need. use and supply of cardiol- 
ogists are at hand and can be used. Therefore, we fiecom- 
mend that the College initiate a panel, perhaps in concert 
with other appropriate organizations and groups, to under- 
take the task of matching these findings and to fashion 
standards of adequacy relating to the following aspects of 
cardiology: access. effectiveness, appropriateness and LOS!. 
. Rapidly changing practice patterns will require freqwnt 
rccxaminations of nssumptions. 
l Ongoing data regarding the actual roles and functions 
performed by cardiologists are needed and can be obtained 
from Fellows of the ACC. 
. Local judgments and data bases derived from local 
experience arc needed to infon local decision makers. 
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I. Demographic Trends in the United States tions considered to be “middle” regarding lifetime births per 
A demographic analysis of the United S;atcs population woman (1.9). life expectancy of 81 years for those born in 
in relation to projecting cardiology manpowrr requires con- 2080 and a yearly net immigration of 450,ooO. the projected 
aiderable focusing d questions because of the enormous United States population is 268 million in 2WO. 305 million in 
amount of data ori this subject. In 1982 the populiltion of the 2030 and 3 I I million in 2080 (Fig. I). Thus, a major increase 
United States was estrnated to be 232 million. Projections in growth of the population will occur within the next 50 
fur the size of the United States population are available years. 
from the Bureau of Census (II. If one uses a set of assump- The distribution of the 1982 population by age and gender 
Figure I. Projection f growth in the popularian based on a set of 
aswmplionr ar de6ned in the km*. The upper lim refers 10 thz 
highest projected growth rater. the middle lint to a rmddle rer of 
asrumptioos and the lowest line to the lowert set of arsumptionr 
regarding population growth. Source: Current Population Reponi. 
U.S. Department ofCommerce. Bureau of the Census. Series P. 23. 
No. 952. 
and projections for the years ZCW, 2030 and 2080 are shown 
in the population pyramids of Figure 2 (1). Not only is the 
population aging, but an increasing proportion of the elderly 
is female (1.21, a fact of imponance as one analyzes trends in 
cardiovascular disease incidence (31. The older population 
has experienced an increased longevity with 2.7 million 
cwsons older than aae 85. reoresentina 22-fold increase as 
&npared with I9CQ~ A child born m-1985 could expect to 
live 74.7 years, whereas a person reaching age 65 in 1985 had 
an average life expectancy of 16.8 years (18.6 for women and 
14.6formenj. Ofnote is the fact that in 1985.4% ofpersons 
65 or older lived in eight populous states (California, New 
York, Florida. Illinois. Michiazn, Ohio, Pennsylvania, Tex- 
as) (4). 
The basis for the increasing proportion of the population 
65 years of age and older relates both to binh rates and to 
declines in awetwiiic mwtalitv. Some moiect a slowine of 
the growth I’n tie elderly pop&ion d&g the IWs~be- 
cause of the relativelv low fertilitv rates in the 1930s. with a 
rapid increase betwekn 2010 and.2030. 
Data on the distribution of race within the United States 
population is based primarily on white as compared with 
“black and other races” combined. In 1982. 14.5% of the 
United Slates population was black and othe;races. Projec- 
lions for future distribution of blacks and other races include 
l6.% in 2OW 20.7% in 2030. and 25.5% in 2080 II). The 
second largest minority in the 1980census was Hispanic wth 
14.6 million (6.45%) persons of diverse background. Yu (5) 
has repotted that Asians are the most rapidly growing 
segment of United States population. The census derigna- 
tion native American includes American Indians. Eskimos 
and Aleuts. This group comprised 0.6% of the United States 
twpulation in 1980. an increae from 0.4% in the 1970 census 
i6,. 
Major changes in melropolitan versus nonmetropolitan 
grrwfh rmes have occurred between the 1970s and 1980s; 
growth in the nonmetropolitan population since 1980 has 
been markedly siower than Lhal in the metropolitan popula- 
tion (7). An exception to this appears lo be in New England. 
Mideast and Great Lakes regions. three highly urbanized 
areas (8). It is difficult to project future nonmetropolitan and 
mefropolilan growth rates with any degree of certainty. 
In terms of regional diwibulion ofthe population. there is 
a cominuinS trend of migration to the Sunbelt. panicularly 
California. Texas and Florida. Recent economic problems 
related to the oil industry have led to a net outmigration from 
Texas. manly to Florida. Tennessee, Georgia, Alabama. 
North Carolina, Virginia and also California (9). 
These estimates and projections emphasize the aging of 
the United States populalion with an increasing percent of 
the elderly being female, many of whom live alone, and with 
an increasing proportion of minorities; both of these changes 
will likely have a major impacl on health ewe needs. 
II. Epidemiologic Trends and Projections of 
Fulure Incidence Rates for Selected 
Cardiovascular Diseases 
Trends in specific disease categories may also influence 
cardiovascular practice in the future. Although mortality 
rates have declined markrdly. morbidity and mortality from 
the cardiovascular diseases remain at high levels (Table I). 
A. Corotzary Heart D&m@ 
The decline in cardiovascular mortalily observed in the 
United Sfates (Fig. 3) has been impressive. with evidence 
favoring a contribution from risk factor control and treat- 
ment effects (10-12). However, the influence of other un- 
known factors and trends in incidence and case fatality is not 
entirely clear. An intriguing regional difference in coronary 
mortality rates (Fig. 4) is unexplained (13). The observed 
decline in monality rates does not imply a lessened impor- 
tance of coronary heart disease as a major health problem. 
Because of the increasing United States population and its 
high component of elderly. one can expect an increase in 
absolute numbers of patients with coronary heart disease. 
Risk factor eonlrol YCPSUS population grorrth. Wemrrem 
et al. (14) hzve used compotcr modeling techniques to 
oroiect coronary heart disease incidence. orevalence and 
mortality given variable assumptions about Ask factor con- 
trol. If cohofi-specific risk factor distributions rerrw simt- 
lar, they project about a IO% decline in the coronary heart 
disease briderice rate in 2010 compared with 1980. How- 
wer, the absolute incidence of “es coronary heart disease 
case5 in the population aged 35 to 84 years IS projected to 
increase from about 690,wO per year in ,980 to abou: 
950,oW oer year in 2010 because of #be incrcasc in the 
papulati& (Table 2). If there are no changes in the life 
expectancy of patients with coronary heart disease. then the 
prevalence, mortality and cost of coronary heart di:ease wdl 
similarly increase by about 50%. The increase in prevalenw 
will be especially marked in persons who are aged 45 to 64 in 
the year 2010. because there patients represent the post- 
World War II baby boom generation (Table 3). In the 2 
decades after 2010, the baby-boom generation will continue 
to age and will further increase the burden of prevalenl 
caronarv heart disease. 
TO k&p the obsohrre incidence of coronary heart dissaae 
in men aged 45 to64 in the year 2010 the same es that in 1980, 
unprecedented reductions’m risk factms would be required 
For example. one way to make a sufficient reduction in 
incidence rates to maintain an unchanged absolute incidence 
would be if the following were to occur: men have a mean 
cholesterol level <ZOO mgldl: all men have a normal diastolic 
blood pressure with a mean level of 81 mm Hg: smoking 
rates are reduced by 50%; there risk factors do not change 
with advancing age; and men whore risk factors were 
lowered by interventions have the same risks of coronary 
heart disease as do men who naturallv have the sane r&k 
factor statw. 
If cardiovascular care improves so that the cabe fatality 
rate of cardiac events Calls and the life expectancy of patients 
with coronary hean diseeaac increase%, the prevalence of 
coronary heart disease will incre:~sc even more. For exaro- 
pie, B 20% reduction in case fatabty rates can be translated 
tnm ahout B PA increaw in the prevalence of coronary heart 
dw:~w in the aeady state. Convenely, if improvementr tn 
rl\k facrw d:wibutvx\ reduce Ihe mcidencc of coronary 
heart d~\eac. the prevalcncc will decrrass. Bccauss of the 
demosrapb~i of the incrcarinF: ooeulation. howcvcr. the 
prcvnlcncc of coronary hean d&ease would ctill ri?e by 
about 3O‘A bv the war ZOI eveo if there were a ZGS 
reduction in &e f&lity rate\ combined with a 25% redur- 
1100 m !ncldence ra!es. Thu. these dramatic improvements 
.;I nsk ta~ton and in medical care would actunlly be assoc,. 
iucd wth iin incrcascd burden of pravalenr coronary hem, 
dwxse 
1,~ rumcrory, the gratifyins decline in coronx) heart 
dwax death rates smee the mid 19605 should not lull 
phywans ?nd bcallh plannen into a false hcnfe of wxrity. 
Epldemm!oglc data clearly demonstrate that demogmphic 
+ifu will acLuatty increase the burden cf cardiac dtsease. 
and c,pccially the burden of conpbcated caidiavasculnr 
disease. even if there are substantial reduaions in incidence 
rates. Furthemore, it may be expected that improved diag- 
noetic technologies will result m earlier recognition of pre- 
cbnical disease for which cardinlogic interventions may 
prove 10 be benefictal. 
Data from the National Heallh examtnalion surveys show 
that mean systolic blood pressurea in persons 18 to 74 year5 
of age decreased between l9@I and 1962 and 1976 and 1980 
05.163. The proportion of persons with hypertension 0.e.. 
there with systolic blood pressure zlM) mm Hg or diastolic 
blood pressure 295 mm HE or taking antthypenensive 
medication) changed very little between those years. On Ihe 
other hand. the propmuon of persons with undiagnosed 
hypertension decreased substantially; the proportion of all 
pcrsonc taking antibypenensive medication increased rub 
ttantially and the orooortion of patients with controlled 
hypenension increased. When hypertension is defined more 
broadI!< (i.e.. blood ltressore rl40Ml mm H.e or one of 
ant~hy&teasive me&atron) similar Vends o&aired, but 
the overall prevalence amounts to an estimated SE million 
persons, one-third of the adult population (17). Given the 
trends smce I%0 through 1962. appreciable reduction i the 
proportion of the population with hypertension cannot be 
expected in the future. In light of recent studies, evaluation 
of cardiac dysfunction early in the eour~e of hypertension 
probably will become nmre common and may be cxpecwd to 
alter patterns of treatment. creating greater complexity in 
the management of the hywrtentenrire patient. 
The nationwide eRon since 1972 to increase the aware- 
ness. treatment and conrrol of hypenension has apparently 
be-c C!?PCI~YP jedeed by the changes observed in the 
national health examination surveys of I%0 to 1962, 1971 to 
1972and 197610 1980(15,16). Thesetrendscoincide with the 
decline in the death rate for stroke (Table 3). Given the 
association between high blood pressure and stroke, the 
implication has been drawn !hat improvements in treatmen! 
and control of hypertension may have contributed to the 
decline in stroke tttortality (IO-12,18-20). Although at least 
one community survey reported a decline in the incidence of 
stroke (21), the rapid decline in stroke mortality and an 
increase in overall life expectancy probably will result in an 
increase in prevalence, which for 1985 was an estimated 2.7 
million persons (22). Moreover. to project further decreases 
in the annual numberofdeaths from stroke. now 150,OCQper 
year, would requtre continuation of the death rate decline at 
E very steep rate. The importance ofdiUuse vascular disease 
d&ol& as the gopniation ages deserves emphasis be- 
cause patients with this condition prewtt complex clinical 
management problems. 
As life expectancy lengthens and survivors of coronary 
heart disease increase. the prevalence of heart failure will 
likely increase much beyond the estimated 2.3 million per- 
sons who now have this cardiovascular condition (23). Heart 
failure already has become the leading Dignosis. Related 
Group in hospitalized patients aged ~65 years (241. With 
only n 5tl% 5 year sur&al rate, this d&e conslitutes a 
large and growing medical problem facing cardiologists. 
ldlwdhic dlIatwJ urdiomyopntby. The assessment of 
national trends in the incidence of idiopathic dilated cardio- 
myopathy, an imporlanl cause of heart failure, is imprecise 
for many reasons: a) the diagnosis is partly one of exclusion 
and depends on the extent of the investigations aimed at 
excluding other canses of heart failure or cardiac dysfunc- 
tion; b) cardiomyopathy has in the past received multiple 
deaianations, making retrospective assessments difficult; c) 
there is paucity of epidemiologic data on the incidence and 
prevalence of dilated cardiomyopathy. 
In 1970. only 8,!XN patients had a discharge diagnosis of 
cardiomyopathy as a primary diagnosis, and this number had 
risen to 32$Xl by l97a and to 46,-m in 1962. It is considered 
likely that this increase is the result of earlier and more 
frequent detection, rather than an actual increase in the 
incidence of the disease. In 1982. IO.345 deaths were attrib- 
uted lo cardiomyopathy according to the National Center for 
Health Statistics (25,26,27). Eighty percent of these tvere 
attributed to idiopathic dilated cardiomyopathy (primary). 
The 1982 age-adjusted prevalence rates for persons aged 35 
to 74 years were I I per KM.CQO (white men). 4.4 per 100,ooO 
(white women), 27 per ltM,oM) (black men), and II per 
1oO.ooO (black womenI. While United States data are not 
sutTIcicnt lo project future trends. Tarp (28) from Malmo. 
Sweden has published epidemiologic data that suggest that 
the incidence of cardiomyopathy is increasing. 
fn summary, it alpears that the incidence of dilated 
cardiomyopathy in the United States ranges from 7 to IO per 
lOO.ooO patients. While it is likely that changing technology 
leading to earlier detection of the disease at a milder stage 
rrwls to “apparent” increase in incidence and prevalence, 
available data outside the United States suggest that a real 
increase in incidence also may be occurring. 
D. Valvular Heart Disease 
A consistent decline in acute rheumatic fever has been 
renotted over the past several decades (29.30): however. a 
r&n1 repon (31) described a resurgence of acute rheumatic 
fever in the intermonntain area of the United States. This 
sudden inweare in acute rheumatic fever occurred in chil- 
dren of law families with above average income and 96% 
were while: overcrowding may have been a contributory 
factor. it aeetn~ unlikely that reeurrenee of acute rheumatic 
fever will have a major impact on cardiovascular disease 
over the next several decades, but continued awareness of 
its potential seems important. 
Passik (32) and Olson (33) and their coworkers studied the 
trend in pathology of amtie and mitral valves leading to the 
need for vaIvular heart surgery. A clear decline in post 
inflammatory valve disease has been observed and is &n- 
sistent with the aging population who have more degenera- 
tive valvular disease. Given the increased growth of the 
United States population and the percent of the population 
older than 65 years, an increased prevalence of patients with 
severe valvular heart disew, pardcularly of the aorlic 
valve, may be pmjected. The inrpacl of catheter balloon 
valvulo~last~ on this problem .is uncertain. The aucceas of 
cardiac~surgery has led to an increasing segment of our 
population surviving with Prosthetic heart valves. These 
patients will continue to require health care services of an 
increasingly complex nature, and in many with prostheses, 
reaperation will be required. again with an increasing need 
for highly sophisticated care. 
E. Congenifal Heart Disease 
Projections for future trends in conaenital heart disease 
must take into account not only the &pected number of 
infants with conaenital heart disease per number of live 
births, but the impact of early sttrg~al efforts and the 
influence uf survivors having children of their own. The 
expected rate of occurrence of congenital heart disease is a/ 
too0 live births, and there is a 1% incidence rate of congen- 
ital heart disease in the apparently normaI population: the 
rate is 2 to 6% for a second pregnancy after birth of a child 
with congenital heart disease and 20 to 36% for a third child 
if the prior two children have congenital hean disease (34). 
Conflicting data are available on the likelihood of survivors 
with congenital heart disease having children with these 
cardiac defect: Nore et al. (35) reported occurrence mtcs of 
I to 5%. but Rare et al. (36) reporred rates of 8.8% in a 
selected series of patients with atrial septal defect. coarcta- 
lion of the aorta, aonic valve stenosis or complex dextro- 
wrdia. and Whittemore et al. (37) found an occurrence rate 
of 16.1% in children bore of mothers with congenital hem 
disease. These figures hould be noted carefutfy and comtd- 
wed with the growing number of patients surviving cardiac 
SUIWY. because increasing experience indicates that as 
these ~tatiettts survive to adolescence and adulthood, unique 
problems are encountered that will increase demands oil 
cardiology manpower. Thus, it is clear tha! au increasing 
number of patients with congenital hem direase can be 
predicted, many of whom wilt survive and require care for 
long periods after cardiac surgery. 
IJI. Cardiovasadar Disease in Minorities 
The importance of cardiovascu:z d;*rase in blacks and 
other minority groups deserves emphasis. important intro- 
attd interracial and ethnic differences in patterns of card& 
vascular disease have been demonstrated and remain uuer- 
plained. Thus, the decline in corona! heart disease mortal- 
ity has become less steep in black men and women than in 
white men (38). 
The 1985 Report of the Secretary’s Task Force on Black 
attd Minority Health (6) provides a resource for additional 
data and recommendations on this problem. Some coaclu- 
sions reached by the Secretary’s Task Force include the 
followittg: 
A. If mortality rates in blwks were reduced to the wee 
rates as in whites. 60,603 fewer deaths in blacks would 
occur each year. Cardiovascular mortality eccount~ for 
more than 40% of this excew death in black women and 
more than 20% of this excess in black mea. 
FJ. The prevalence of coronary heart disease appears to be 
similar in black men and white men, but to he greater in 
black women than in white women, whereas the preva- 
lence and severity of hypertension is substantially great- 
er in the black population than in the white population. 
C. Major socioeconomic dilTerenti& exist between the 
black and white populations and a&t their respective 
life experiettces, biologic risk factor distributions and 
access to medical care. Blacks make fewer tice visits 
for coronary disease than do whites, and are less likely to 
be seen by cardiovexuler disease specialists. 
D. Another consequence of the relatively small number of 
black physicians is the very low likelihood that a black 
patient would be seen by a black cardiologist, with whom 
there would be more culiural tinily. The best available 
infommtion on the number of black cardiologists who 
have Board Certification in Cardiovascular Disease is 
E 
from the retards of the Ass&alien oi Slack Cvdiolc- 
gtstn. ‘There are fewer than 80 such physiciatn in the 
United States. Lack of awareness among home white 
-bystcians, by whom ost black pat&s are seen. of the 
importance of coronary disease in blacks may have an 
advene impact on diagnostic and therapeutic practices. 
Despite limited coronary heart disease mortality data, 
cardiovascular disease is also a major cause of death in 
Hispanics. although the mte is somewhat higher for 
non-Hispanic whites. This lower relative rate is unex- 
pected m view of the socioeconomic profile of Hispanics, 
the pronounced rural to urban migration and high prc- 
p.?ion of immigrants and the prevalence af obesity and 
diabetes. pert xdarly in women. 
F. Heart direax is the leadicg cause of death for all Amer- 
ican OtientaliAsian groups. Some regional data weat to 
indicate that with the possible exception of stroke, 
Asians are at lower risk of mortality from vascular 
disease than are other minariries and whites. Oriental/ 
Asmn immigrant men appear to be developing corenary 
:~cP; diceme at a younger age than do the men in their 
native councr;cs. P~tan fcmen appear to be at lower risk 
than men in all ethnic subgroups; Koreans. Filioinos and 
Chinese appear to he at lower risk of cardiovascular 
disease than are Japanese men and women. 
G. Heert disease is a significant contributor to ell-cause 
mortality in Native Americans, but is proportionately 
less of a contributor than in the general popttlation. 
Available data, however. point to a pattern of increasing 
coronary heart disease incidence in certain u-;an Native 
Americans, whereas data for Southwestern tribes indi- 
cate a low prevalence of coronary heart disease despite 
high rates of obesity end diabetes and increasing hyper- 
ten&m rate*. 
H. Black and other minorily groups are particularly likely to 
be underinsured or not insured for medical care. 
IV. coorlUsiona 
In summary, we project a major increase in the size of the 
general population. Moreover, there will be a substantial 
increase in the proportion of the population age a65 years. 
as well as those in racial or ethnic minority groups. These 
changes in the population, fxn if accompanied by the most 
optimisttf predictions of reduced cardiovascular mortality 
rates, will result in an increase in prevalence of cardiovas- 
cular diseme. Furthermore, as a result of that survival and 
the evidence of beneficial application of new and therapeutic 
diagnostic techniques, it teems resonable to predict that 
there will be an increase in the prevaleuce of more complex 
and more readily recognized cardiovascular disease. All of 
these factors suggest that there will be a need for more 
resources to care for the cardiovascular problems of the 
United States population. These datacan and should be used 
for estimate5 needs ror physician 
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